Millennium Management LLC sold $77k of FTH
owner at Sensei Biotherapeutics, Inc.. 2,741 shares at an average of $28.07, traded Mar 31, 2026, filed May 15, 2026.
Score components
- +12Role10% owner
- +8Trade size$77k at market
- 0Share of holdings soldSold 1.9% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -36.4%, 3m +58.3%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-26-062605, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | POpen-market purchase Common Stockindirect: See footnote | +616 | $24.69 | $15k | 146,657 | May 15, 2026 |
| Mar 31, 2026 | POpen-market purchase Common Stockindirect: See footnote | +1,770 | $25.32 | $45k | 146,657 | May 15, 2026 |
| Mar 31, 2026 | POpen-market purchase Common Stockindirect: See footnote | +1,048 | $26.73 | $28k | 146,657 | May 15, 2026 |
| Mar 31, 2026 | POpen-market purchase Common Stockindirect: See footnote | +17 | $27.78 | $472 | 146,657 | May 15, 2026 |
| Mar 31, 2026 | POpen-market purchase Common Stockindirect: See footnote | +186 | $30.48 | $5,668 | 146,657 | May 15, 2026 |
| Mar 31, 2026 | POpen-market purchase Common Stockindirect: See footnote | +1,957 | $31.45 | $62k | 146,657 | May 15, 2026 |
| Mar 31, 2026 | POpen-market purchase Common Stockindirect: See footnote | +411 | $32.60 | $13k | 146,657 | May 15, 2026 |
| Mar 31, 2026 | SOpen-market sale Common Stockindirect: See footnote | -191 | $24.28 | $4,638 | 146,657 | May 15, 2026 |
| Mar 31, 2026 | SOpen-market sale Common Stockindirect: See footnote | -1,251 | $25.17 | $31k | 146,657 | May 15, 2026 |
| Mar 31, 2026 | SOpen-market sale Common Stockindirect: See footnote | -57 | $27.11 | $1,546 | 146,657 | May 15, 2026 |
| Mar 31, 2026 | SOpen-market sale Common Stockindirect: See footnote | -5 | $28.41 | $142 | 146,657 | May 15, 2026 |
| Mar 31, 2026 | SOpen-market sale Common Stockindirect: See footnote | -87 | $31.52 | $2,742 | 146,657 | May 15, 2026 |
| Apr 1, 2026 | POpen-market purchase Common Stockindirect: See footnote | +1,161 | $31.53 | $37k | 147,731 | May 15, 2026 |
| Apr 1, 2026 | POpen-market purchase Common Stockindirect: See footnote | +1,613 | $34.59 | $56k | 147,731 | May 15, 2026 |
| Apr 1, 2026 | POpen-market purchase Common Stockindirect: See footnote | +3,401 | $35.46 | $121k | 147,731 | May 15, 2026 |
| Apr 1, 2026 | SOpen-market sale Common Stockindirect: See footnote | -1,104 | $31.52 | $35k | 147,731 | May 15, 2026 |
| Apr 1, 2026 | SOpen-market sale Common Stockindirect: See footnote | -46 | $34.75 | $1,598 | 147,731 | May 15, 2026 |
Related signals
Other insiders at Sensei Biotherapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 64Notable | Sensei Biotherapeutics, Inc. | Brian C Stephenson Chief Financial Officer | $326k 13,634 shares | +41% | |
| 69Notable | Sensei Biotherapeutics, Inc. | Brian C Stephenson Chief Financial Officer | $401k 15,641 shares | +90% | |
| 62Notable | Sensei Biotherapeutics, Inc. | Brian C Stephenson Chief Financial Officer | $406k 17,413 shares | - | |
| 43Moderate | Sensei Biotherapeutics, Inc. | Anand Kiran Parikh President and CEO | $55k 2,806 shares | +0% | |
| 43Moderate | Sensei Biotherapeutics, Inc. | Cambrian BioPharma Inc owner | $501k 25,000 shares | -16% | |
| 43Moderate | Sensei Biotherapeutics, Inc. | James Peyer owner, other | $501k 25,000 shares | -16% | |
| 39Weak | FTHbuy Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $818k 30,585 shares | +23% | |
| 21Weak | FTHsell Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $89k 3,250 shares | -2% | |
| 31Weak | FTHbuy Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $382k 12,180 shares | +8% | |
| 23Weak | FTHbuy Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $141k 4,215 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.